Publikationen, an denen er mitarbeitet Mario Fernández Fraga (7)

2023

  1. The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent

    Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895

2018

  1. MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis

    Cell Death and Disease, Vol. 9, Núm. 10

2014

  1. S-adenosylmethionine levels regulate the schwann cell DNA methylome

    Neuron, Vol. 81, Núm. 5, pp. 1024-1039

2013

  1. A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma

    Journal of Molecular Medicine, Vol. 91, Núm. 8, pp. 939-950

2010

  1. Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide

    Hepatology, Vol. 52, Núm. 1, pp. 105-114

2009

  1. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect

    Oncogene, Vol. 28, Núm. 6, pp. 781-791

  2. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect (Oncogene (2009) 28, (781-791) DOI: 10.1038/onc.2008.436)

    Oncogene